Carcinoma, Non-Small-Cell Lung: all 6,641 studies
Page 4 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.
- A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung CancerRecruitingNCT07439094Phase 1/2
- Study of Sacituzumab Tirumotecan Combined With Toripalimab for Resectable Stage II-IIIB NSCLCNot yet recruitingNCT07438600Phase 2
- Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung CancerRecruitingNCT07436858Phase 1
- 3D Virtual Resection for Predicting Lung Function in VATSRecruitingNCT07436598
- Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRecruitingNCT07435038Phase 1/2
- Study of Three Endpoints to Assess the Benefit of Rehabilitation in Patients With Advanced Non-small Cell Lung Cancer Controlled After at Least 6 Months of Systemic TreatmentRecruitingNCT07434947
- Fecal Microbiota Transplant(FMT) Combination With Tislelizumab in Advanced or Metastatic NSCLCNot yet recruitingNCT07432984Phase 2
- Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung CancerRecruitingNCT07432802Not applicable
- MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)RecruitingNCT07431827Phase 3
- A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard TherapyNot yet recruitingNCT07423117Phase 1
- A Real-world Study of Pralsetinib Combined With Leucogen in the Treatment of RET Fusion-positive NSCLCNot yet recruitingNCT07418879Not applicable
- FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung CancerNot yet recruitingNCT07418866Phase 2
- Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung CancerRecruitingNCT07416994Phase 3
- RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)RecruitingNCT07416474Phase 3
- CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLCRecruitingNCT07413757
- A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) ExpressionRecruitingNCT07412262Phase 2
- Precise Exercise Regimen for Cancer Care (PERCC): A Pilot StudyRecruitingNCT07412041Not applicable
- Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung CancerRecruitingNCT07410975Phase 2
- ctDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With RadiotherapyNot yet recruitingNCT07410611Phase 2
- Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsRecruitingNCT07410494Phase 1/2
- IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung CancerRecruitingNCT07408635Phase 2
- Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLCRecruitingNCT07405190Phase 2
- Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyRecruitingNCT07405086Phase 4
- Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung LesionsRecruitingNCT07401615
- Preoperative Structured Exercise Programme on Patients With Non-Small Cell Lung CancerNot yet recruitingNCT07401056Not applicable
- Anlotinib in Cross-line Treatment of NSCLC and SCLCNot yet recruitingNCT07400575
- Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II StudyRecruitingNCT07398599Not applicable
- GCC 2546- Motion ManagementRecruitingNCT07398209Not applicable
- Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid TumorsRecruitingNCT07397338Phase 1/2
- Real-World Comparison of Chemo-Immunotherapy Regimens in Metastatic NSCLC With PD-L1 <50% (ALCG-01)RecruitingNCT07394062
- Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)RecruitingNCT07393555Phase 2
- Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.RecruitingNCT07392658Phase 2
- Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLCNot yet recruitingNCT07392073
- A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous DurvalumabRecruitingNCT07391670Phase 1
- A Study of SH009 Injection in Patients With Advanced Solid Tumors.RecruitingNCT07390838Phase 1
- Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC TrialRecruitingNCT07388524Phase 3
- Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung DiseaseRecruitingNCT07384897Not applicable
- Lung Cancer Screening in Population Who Had Never SmokedNot yet recruitingNCT07383454Not applicable
- Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A TrialRecruitingNCT07382726Phase 1
- Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung CancerRecruitingNCT07379476Phase 2
- Clinical Study of SHR-A1811 Combined With Pertuzumab as Second-Line Therapy in Patients With HER2-Altered Advanced NSCLCNot yet recruitingNCT07377916Not applicable
- A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid TumorsRecruitingNCT07376707Phase 1
- Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle AnalysisNot yet recruitingNCT07376512
- A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positive ctDNA After lead-in Osimertinib MonotherapyRecruitingNCT07375316Phase 2
- Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After LorlatinibRecruitingNCT07374614
- Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival AnalysisEnrolling by invitationNCT07373951
- Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label StudyEnrolling by invitationNCT07373899
- Association of Different Tidal Volumes and Postoperative Pulmonary ComplicationsNot yet recruitingNCT07372378
- An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsRecruitingNCT07371663Phase 1/2
- Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety StudyNot yet recruitingNCT07365410Phase 2
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.RecruitingNCT07365319Phase 2/3
- Large Granular Lymphocytes in mNSCLC Treated With NivolumabRecruitingNCT07363811
- A Phase Ⅰ/Ⅱa Clinical Study of GEN-725 in Combination With DositinibRecruitingNCT07362940Phase 1/2
- A Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer.RecruitingNCT07362459Phase 3
- A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid TumorsRecruitingNCT07361562Phase 1
- A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)RecruitingNCT07361510Phase 3
- A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)RecruitingNCT07361497Phase 3
- Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)Not yet recruitingNCT07361484Phase 3
- A Phase l Clinical Study to Evalute the Safety,Tolerability,Pharmacokinetic Characteristics,and Preliminary Anti-tumor Efficacy of HJ-004-02 Tablets in Patients With Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) MutationsRecruitingNCT07361237Phase 1
- Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 LevelsRecruitingNCT07360743Phase 2
- Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung CancerRecruitingNCT07359040
- First in Human Study of QLS5316 in Solid TumorsNot yet recruitingNCT07358884Phase 1
- Study to Assess the Effect of OCT-598 in Patients With Advanced Solid TumorsRecruitingNCT07358806Phase 1
- Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLCRecruitingNCT07356544
- Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRINot yet recruitingNCT07355231Phase 1/2
- First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung CancerRecruitingNCT07355205Phase 1/2
- Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)RecruitingNCT07354061Phase 1/2
- Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLCNot yet recruitingNCT07353476Phase 2
- Chemotherapy Plus Pitavastatin Guided by Patient-Derived Tumor-like Cell Clusters in Refractory Non-Small Cell Lung CancerNot yet recruitingNCT07351565Phase 1
- Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid TumorsRecruitingNCT07349537Phase 1
- Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal MetastasisRecruitingNCT07348965Not applicable
- First in Human Study of SIM0610 in Solid TumorsRecruitingNCT07348211Phase 1
- Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis RiskNot yet recruitingNCT07347977Not applicable
- Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain MetastasesNot yet recruitingNCT07343479Phase 2
- SL-28 for Advanced Solid TumoursRecruitingNCT07341737Phase 1/2
- Glecirasib Combined With Ivonescimab for First-line Treatment of KRAS G12C-mutated NSCLCNot yet recruitingNCT07339839Phase 1/2
- Experiences w/ & Attitudes Towards Immune Chckpt Inhibitors in NSCLC Patients Single Center Survey Based StudyRecruitingNCT07339254
- Intratumoral N17350 in Advanced Solid TumorsRecruitingNCT07339176Phase 1/2
- Electro-Acupuncture in Lung cancER : EALER StudyRecruitingNCT07337096Not applicable
- Andamertinib With or Without Platinum-doublet Chemotherapy Versus Platinum-doublet Chemotherapy in Patients With NSCLC Harboring Atypical EGFR MutationsRecruitingNCT07336732Phase 2
- Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsRecruitingNCT07334119Phase 1
- 125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal CancerNot yet recruitingNCT07333651Phase 2
- First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural EffusionRecruitingNCT07332858Phase 1/2
- QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLCRecruitingNCT07330596Phase 2
- WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLCRecruitingNCT07330050Phase 2
- Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerRecruitingNCT07329322Phase 2
- Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung CancerRecruitingNCT07328945
- Anesthesia Comparison in Early-stage Small NSCLC: A Multicenter RCTNot yet recruitingNCT07327736Not applicable
- Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)RecruitingNCT07327489
- Molecular Phenotyping of Primitive Lung Cancer and Metastatic SiteRecruitingNCT07325864
- A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung DiseaseRecruitingNCT07323732Phase 2
- Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung CancerRecruitingNCT07323641Phase 2
- Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung CancerRecruitingNCT07323056Phase 2
- SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung CancerRecruitingNCT07322341Phase 2
- Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)RecruitingNCT07320105Phase 4
- NK-cell Therapy Combined With PD-1 Antibody and Platinum-Based Chemotherapy as Neoadjuvant Therapy in Resectable NSCLCNot yet recruitingNCT07318636Phase 1
- A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in ChinaRecruitingNCT07316062
- Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung CancerRecruitingNCT07315113Phase 1
- Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary AdenocarcinomaRecruitingNCT07314216Phase 2
- Effects of a Visual Interactive LINE Chatbot on Self-Management of EGFR-TKI Related Side Effects in Patients With Lung CancerNot yet recruitingNCT07310589Not applicable